Adjuvant!© Online estimation of chemotherapy effectiveness when added to ovarian function suppression plus tamoxifen for premenopausal women with estrogen-receptor-positive breast cancer

Author： Paridaens Robert   Gelber Shari   Cole Bernard   Gelber Richard   Thürlimann Beat   Price Karen   Holmberg Stig   Crivellari Diana   Coates Alan   Goldhirsch Aron  

Publisher： Springer Publishing Company

ISSN： 0167-6806

Source： Breast Cancer Research and Treatment, Vol.123, Iss.1, 2010-08, pp. : 303-310

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Adjuvant tamoxifen-induced mammographic breast density reduction as a predictor for recurrence in estrogen receptor-positive premenopausal breast cancer patients

By Ko Kyung   Shin In   You Ji   Jung So-Youn   Ro Jungsil   Lee Eun  

Breast Cancer Research and Treatment, Vol. 142, Iss. 3, 2013-12 ,pp. : 559-567

Springer Publishing Company

Access to resources Recommend Favorite

Tamoxifen Added to Adjuvant Chemotherapy in Premenopausal Women with Early Breast Cancer: is it Standard Practice or Still a Subject for Study?

By Bramwell V.H.C.   Pritchard K.I.  

European Journal of Cancer, Vol. 35, Iss. 12, 1999-11 ,pp. : 1625-1627

Elsevier

Access to resources Recommend Favorite

Ovarian hyperstimulation in premenopausal women during adjuvant tamoxifen treatment for endocrinedependent breast cancer: A report of two cases

By          

Oncology Letters, Vol. 8, Iss. 3, 2014-01 ,pp. : 1279-1282

Spandidos Publications

Access to resources Recommend Favorite

Adjuvant Ovarian Suppression Versus Chemotherapy for Premenopausal, Hormone-responsive Breast Cancer: Quality of Life and Efficacy Tradeoffs

By Elkin Elena   Weinstein Milton   Kuntz Karen   Bunnell Craig   Weeks Jane  

Breast Cancer Research and Treatment, Vol. 93, Iss. 1, 2005-09 ,pp. : 25-34

Springer Publishing Company

Access to resources Recommend Favorite

Letrozole plus GnRH analogue as preoperative and adjuvant therapy in premenopausal women with ER positive locally advanced breast cancer

By Torrisi Rosalba  

Breast Cancer Research and Treatment, Vol. 126, Iss. 2, 2011-04 ,pp. : 431-441

Springer Publishing Company

Access to resources Recommend Favorite